Get started
Author

Emily Tharp

Observed name: Tharp, Emily
ORCID: 0009-0006-7371-8680
Observed ORCID: 0009-0006-7371-8680
OpenAlex ID: A5076159170
Buprenorphine Medication for Opioid Use Disorder: A Study of Factors Associated With Postpartum Treatment Retention
2020 · Shona Ray‐Griffith, Emily Tharp, et al. · American Journal on Addictions · 19
Allogeneic Bone Marrow‐Derived Mesenchymal Stem Cells for Parkinson's Disease: A Randomized Trial
2025 · Mya C. Schiess, Jessika Suescun, et al. · Movement Disorders · 11
PDF
Allogeneic bone marrow-derived mesenchymal stem cells in the aging kidney: secondary results of a Parkinson’s disease clinical trial
2025 · Juan D. Martinez-Lemus, Donald A. Molony, et al. · Stem Cell Research & Therapy · 5
PDF
Role of alpha-synuclein seed amplification assay in Parkinson’s disease clinical trials: A case of misdiagnosis
2024 · Emily Tharp, Juan D. Martinez-Lemus, et al. · Clinical Parkinsonism & Related Disorders · 2
Blood microRNA-7 as a Progression Biomarker in men with Parkinson's disease (S37.006)
2023 · Mya Schiess, Jessika Suescun, et al. · Neurology · 2
Retrospective longitudinal analysis of blood microRNA-7-5p as a possible progression biomarker in people with Parkinson’s disease
2026 · Shayan Abdollah Zadegan, Corrine Hutchinson, et al. · Frontiers in Neuroscience · 1
PDF
Serum Neurofilament Light Chain Levels in Parkinson’s Disease Therapy: Preliminary Results from a Phase 2 Clinical Trial of Allogenic Bone Marrow-derived Mesenchymal Stem Cell (S37.006)
2025 · Juan Martinez Lemus, Emily Tharp, et al. · Neurology · 1
Treatment of refractory post-hypoxic myoclonus and focal epilepsy with subthalamic nuclei deep brain stimulation
2024 · Emily Tharp, Muhammad Ubaid Hafeez, et al. · Parkinsonism & Related Disorders · 1
Design and Baseline characteristic of Phase II clinical trial of allogeneic bone marrow-derived Mesenchymal Stem Cells as a disease-modifying therapy for idiopathic Parkinson’s disease (P1-11.004)
2023 · Mya Schiess, Timothy Ellmore, et al. · Neurology · 1
LGI1 Limbic Encephalitis after Interleukin-2 Therapy (S50.005)
2018 · Bahar Beaver, Sarah Burbank, et al. · Neurology · 1
Supplemental Material for : Revisiting the Link Between Huntington’s Disease and Cancer: Evidence from the Enroll-HD dataset
2026 · figshare admin karger, Natalia Pessoa Rocha, et al. · Figshare
Revisiting the Link between Huntington’s Disease and Cancer: Evidence from the Enroll-HD Dataset
2026 · Natalia Pessoa Rocha, Jack Ringold, et al. · Neuroepidemiology
Is functional neurosurgery offering new hope for patients with hyperkinetic disorders? A mini-review of the current data on the use of DBS in hyperkinetic movement disorders
2026 · Emily Tharp, Raja Mehanna · Parkinsonism & Related Disorders
Clinical and Immunologic Safety Evaluation of Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells in Parkinson’s Disease (P8-17.011)
2026 · Chiamaka Onuigbo, Jerome Saltarrelli, et al. · Neurology
Multimodal Imaging Biomarkers of Substantia Nigra, Locus Coeruleus, and Putamen Perfusion Track Clinical Change in a Randomized Trial of MSC Therapy in Parkinson’s Disease (S43.003)
2026 · Timothy Ellmore, Juan Martinez Lemus, et al. · Neurology
Development of an Artificial Intelligence Framework for Accurate Diagnosis of Synucleinopathies using Clinical Features (P6-16.006)
2026 · Wajih Raza, Juan Martinez Lemus, et al. · Neurology
Bridging Regenerative and Restorative Stem Cell Therapies in Parkinson’s Disease
2026 · Chiamaka Onuigbo, Juan Martinez-Lemus, et al. · Cells
PDF
Motivations and Burdens of Participation in Parkinson’s Disease Clinical Trials: Experiences from a Disease-modifying Phase 2 Study (P11-5.019)
2025 · Emily Tharp, Juan Martinez Lemus, et al. · Neurology
Updated Parkinson's disease motor subtypes classification and correlation to CSF HVA and 5-HIAA levels (P3-11.005)
2023 · Jessika Suescun, Christopher Adams, et al. · Neurology
FMR1, BDNF, and COMT in Functional Movement Disorder Women (P5.027)
2017 · Emily Tharp, Maura Walsh, et al. · Neurology
Works count: 23
Citation count: 44
H-index: 3
I10-index: 2
Year
Topic
Type